about
Recent progress in West Nile virus diagnosis and vaccinationGlobal transport networks and infectious disease spreadEnvironmental and social determinants of human risk during a West Nile virus outbreak in the greater Chicago area, 2002West Nile virus infection and its neurological manifestationsN-Linked Glycosylation of West Nile Virus Envelope Proteins Influences Particle Assembly and InfectivityCleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinaseWest Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral OntarioCleavage preference distinguishes the two-component NS2B–NS3 serine proteinases of Dengue and West Nile virusesExpression and purification of a two-component flaviviral proteinase resistant to autocleavage at the NS2B–NS3 junction regionEstablishment and Maintenance of the Innate Antiviral Response to West Nile Virus Involves both RIG-I and MDA5 Signaling through IPS-1Structure–activity relationship and improved hydrolytic stability of pyrazole derivatives that are allosteric inhibitors of West Nile Virus NS2B-NS3 proteinaseKey role of T cell defects in age-related vulnerability to West Nile virusReverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.Generation of West Nile virus infectious clones containing amino acid insertions between capsid and capsid anchor.Potential disease transmission from wild geese and swans to livestock, poultry and humans: a review of the scientific literature from a One Health perspectiveDIFFERENTIAL IMPACT OF WEST NILE VIRUS ON CALIFORNIA BIRDS.Monitoring of West Nile virus in mosquitoes between 2011-2012 in Hungary.In vitro and in vivo characterization of a West Nile virus MAD78 infectious cloneReducing outbreaks: using international governmental risk pools to fund research and development of infectious disease medicines and vaccines.Current trends in West Nile virus vaccine development.West Nile virus population genetics and evolution.West Nile virus in Morocco, 2003.Extrinsic Incubation Rate is Not Accelerated in Recent California Strains of West Nile Virus in Culex tarsalis (Diptera: Culicidae).Characterization of West Nile viruses isolated from captive American Flamingoes (Phoenicopterus ruber) in Medellin, Colombia.West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection.In Vitro and in Vivo Evaluation of Mutations in the NS Region of Lineage 2 West Nile Virus Associated with Neuroinvasiveness in a Mammalian Model.Ecology of West Nile virus in North America.A review of vaccine approaches for West Nile virus.West Nile virus state of the art report of MALWEST Project.West nile epidemic in louisiana in 2002.A disconnect between precursor frequency, expansion potential, and site-specific CD4+ T cell responses in aged mice.Delineating West Nile Virus Transmission Cycles at Various Scales: The Nearest Neighbor Distance-Time Model.West Nile virus
P2860
Q21284433-49214E21-2084-4A7B-B7C3-71EC1DBEF278Q24576083-1A3F9D57-A389-490F-B28C-A41A9905173DQ24806816-4DE58158-F289-40E8-A81B-1CDD4AD24540Q27469441-E949C008-0FC0-4E21-88C3-F1EDB9500492Q27472669-7EE85343-BC35-415C-BE07-05AE7672B130Q27472859-6F8622AF-FC34-4FCC-978A-A981D9DFCDF1Q27473563-E86C24D0-EC27-466B-823E-F4E4750230D1Q27477953-66DBA54A-55C9-40C8-BCE4-29C7C6E820E2Q27478339-A268E778-C0F0-4C48-97E7-2F169B973A1CQ27485316-62D5EA62-D54A-44DF-9E46-DB0834E32469Q27490391-66665129-3008-4030-876F-57C1F04A1438Q27490802-53768051-6E32-4B47-AD13-3706100735A7Q33570326-62224E18-06CF-408F-8904-4BB41B0DDB04Q33584783-9B9851FB-6F23-4E23-8755-42BB3345C614Q33723388-F35D5275-1BEC-4E71-B60C-8B97C4C386E3Q33943927-5E77F357-D067-4BFF-8A6B-3361C55B2991Q34224516-6BF9AC62-B139-48CC-9537-9E702895E33AQ34356236-AC299E93-E076-43BA-BDA6-268435083616Q34637519-F94386A4-7FEF-4C30-9EDD-695AD5E6A774Q34788758-15C08088-8911-4775-BAF5-6F7EABD61DC7Q35826344-ED9B8FD4-AAC3-41B3-9688-E8BB91015CE9Q35873273-61F29168-D4BC-4B7E-9E0E-B42463C010A6Q36072015-2745B233-4045-4742-AFD0-537DADBF3585Q36213330-E74F12FA-8DDA-4632-9B6C-F638D8F588AAQ36418554-EF19DEE1-5F91-438F-9D89-D696F830DF3FQ36645530-84ADEEBE-D5E3-484E-94F7-8667F2D55416Q37235281-CDD6ABA5-AD55-445D-ABAF-1DA6AFF04701Q37236968-AB0F17C6-FD25-446D-880E-96990C1393FBQ37434776-F451F1A3-E5B2-426A-A235-6F6C5CC06BF2Q40555981-1FFE2BDD-AF4C-470B-B788-43E25B193914Q55096797-0792723A-705D-4F15-8D52-0DB222D2DF60Q55311960-3A2F7F52-27C6-46C8-A847-988D96984C3CQ56932479-D923EC1F-4140-40EB-81A2-9772202A2BCE
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
West Nile virus: Uganda, 1937, to New York City, 1999.
@ast
West Nile virus: Uganda, 1937, to New York City, 1999.
@en
West Nile virus: Uganda, 1937, to New York City, 1999.
@nl
type
label
West Nile virus: Uganda, 1937, to New York City, 1999.
@ast
West Nile virus: Uganda, 1937, to New York City, 1999.
@en
West Nile virus: Uganda, 1937, to New York City, 1999.
@nl
prefLabel
West Nile virus: Uganda, 1937, to New York City, 1999.
@ast
West Nile virus: Uganda, 1937, to New York City, 1999.
@en
West Nile virus: Uganda, 1937, to New York City, 1999.
@nl
P1476
West Nile virus: Uganda, 1937, to New York City, 1999
@en
P2093
P356
10.1111/J.1749-6632.2001.TB02682.X
P407
P577
2001-12-01T00:00:00Z